Free Trial

Mersana Therapeutics (MRSN) SEC Filings & 10K Form

Mersana Therapeutics logo
$0.40 0.00 (-0.58%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.39 -0.01 (-1.94%)
As of 05/2/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Mersana Therapeutics SEC Filings

DateFilerForm TypeView
04/30/2025
10:23 AM
Mersana Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
04/29/2025
5:00 AM
Mersana Therapeutics (Filer)
Form DEF 14A
04/29/2025
5:05 AM
Mersana Therapeutics (Filer)
Form DEFA14A
04/29/2025
5:11 AM
Mersana Therapeutics (Filer)
Form ARS
03/03/2025
7:50 AM
Mersana Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:27 AM
Mersana Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:15 PM
Mersana Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Mersana Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
7:08 AM
Mersana Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
6:20 PM
DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:21 PM
Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:25 PM
Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:26 PM
Mersana Therapeutics (Issuer)
Protopapas Anna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:27 PM
Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:02 PM
Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:04 PM
Mersana Therapeutics (Subject)
Protopapas Anna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:04 PM
Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:05 PM
Carvajal Alejandra (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:05 PM
DeSchuytner Brian (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:05 PM
Lowinger Timothy B (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:18 PM
Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:18 PM
Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
4:19 PM
DeSchuytner Brian (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
4:20 PM
Lowinger Timothy B (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
4:21 PM
Mersana Therapeutics (Subject)
Protopapas Anna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
4:23 PM
Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
4:23 PM
DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
4:24 PM
Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
4:25 PM
Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
4:25 PM
Mersana Therapeutics (Issuer)
Protopapas Anna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:16 PM
Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:17 PM
Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:17 PM
DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:18 PM
Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:19 PM
Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:20 PM
Mersana Therapeutics (Issuer)
Protopapas Anna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:15 PM
Mersana Therapeutics (Subject)
Protopapas Anna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:10 PM
Mersana Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/10/2025
7:32 AM
Mersana Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
3:12 PM
Charoub Ian (Reporting)
Constantinides Costas (Reporting)
Mersana Therapeutics (Issuer)
Nextech Crossover I GP S.a r.l. (Reporting)
NEXTECH CROSSOVER I SCSP (Reporting)
Sgobbo Rocco (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/26/2024
3:29 PM
Mersana Therapeutics (Subject)
Nextech Crossover I GP S.a r.l. (Filed by)
Form SCHEDULE 13G/A
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
12/23/2024
6:50 PM
EcoR1 Capital, LLC (Filed by)
Mersana Therapeutics (Subject)
Form SCHEDULE 13G/A
12/23/2024
6:42 PM
EcoR1 Capital, LLC (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
4:01 PM
Mersana Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:45 PM
Mersana Therapeutics (Subject)
Nextech Crossover I GP S.a r.l. (Filed by)
Form SC 13G/A
11/14/2024
5:01 AM
BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Mersana Therapeutics (Subject)
Form SC 13G/A
11/13/2024
7:50 AM
Mersana Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:27 AM
Mersana Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:43 PM
Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:26 PM
Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
5:55 AM
Mersana Therapeutics (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
10/07/2024
4:46 PM
Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:47 PM
Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:47 PM
Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:48 PM
Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:48 PM
DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:18 PM
Lowinger Timothy B (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2024
4:18 PM
DeSchuytner Brian (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2024
4:19 PM
Carvajal Alejandra (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2024
4:20 PM
Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:08 PM
Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:06 PM
Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
4:08 PM
Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
7:59 AM
Mersana Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:18 AM
Mersana Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
4:31 PM
Hack Andrew A. F. (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:49 PM
Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:51 PM
Dere Willard H (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:51 PM
Diaz Allene M. (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:52 PM
Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:53 PM
Mersana Therapeutics (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:54 PM
Mersana Therapeutics (Issuer)
Protopapas Anna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:26 AM
Mersana Therapeutics (Subject)
Nextech Crossover I GP S.a r.l. (Filed by)
Form SC 13G
05/09/2024
11:15 PM
Mersana Therapeutics (Filer)
Form EFFECT
05/09/2024
4:06 PM
Mersana Therapeutics (Filer)
Form 424B5
05/09/2024
8:00 AM
Mersana Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:10 AM
Mersana Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MRSN) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners